Literature DB >> 19188555

Peroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteine.

Grace O Osoata1, Toyoyuki Hanazawa1, Caterina Brindicci1, Misako Ito1, Peter J Barnes1, Sergei Kharitonov1, Kazuhiro Ito2.   

Abstract

BACKGROUND: Peroxynitrite (PN) formed by the reaction of nitric oxide and superoxide is a powerful oxidant/nitrosant. Nitrative stress is implicated in COPD pathogenesis, but PN has not been detected due to a short half-life (< 1 s) at physiologic condition. Instead, 3-nitrotyrosine has been measured as a footprint of PN release.
METHOD: PN was measured using oxidation of 2',7'-dichlorofluorescein (DCDHF) in exhaled breath condensate (EBC) collected in high pH and sputum cells. The PN scavenging effect was also evaluated by the same system as PN-induced bovine serum albumin (BSA) nitration.
RESULTS: The mean (+/- SD) PN levels in EBC of COPD patients (7.9 +/- 3.0 nmol/L; n = 10) were significantly higher than those of healthy volunteers (2.0 +/- 1.1 nmol/L; p < 0.0001; n = 8) and smokers (2.8 +/- 0.9 nmol/L; p = 0.0017; n = 6). There was a good correlation between PN level and disease severity (FEV(1)) in COPD (p = 0.0016). Fudosteine (FDS), a unique mucolytic antioxidant, showed a stronger scavenging effect of PN than N-acetyl-cysteine on DCDHF oxidation in vitro and in sputum macrophages, and also on PN-induced BSA nitration. FDS (0.1 mmol/L) reduced PN-enhanced interleukin (IL)-1beta-induced IL-8 release and restored corticosteroid sensitivity defected by PN more potently than those induced by H(2)O(2) in A549 airway epithelial cells.
CONCLUSION: This noninvasive PN measurement in EBC may be useful for monitoring airway nitrative stress in COPD. Furthermore, FDS has the potential to inhibit PN-induced events in lung by its scavenging effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188555     DOI: 10.1378/chest.08-2105

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  23 in total

Review 1.  Antioxidant pharmacological therapies for COPD.

Authors:  Irfan Rahman; William MacNee
Journal:  Curr Opin Pharmacol       Date:  2012-02-18       Impact factor: 5.547

Review 2.  Pharmacological antioxidant strategies as therapeutic interventions for COPD.

Authors:  Irfan Rahman
Journal:  Biochim Biophys Acta       Date:  2011-11-09

3.  Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease.

Authors:  Jessy S Deshane; David T Redden; Meiqin Zeng; Marion L Spell; Jaroslaw W Zmijewski; John T Anderson; Rohit J Deshane; Amit Gaggar; Gene P Siegal; Edward Abraham; Mark T Dransfield; David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2014-10-25       Impact factor: 10.793

4.  Oxidative and nitrosative modifications of tropoelastin prevent elastic fiber assembly in vitro.

Authors:  Kamal Akhtar; Thomas J Broekelmann; Ming Miao; Fred W Keeley; Barry C Starcher; Richard A Pierce; Robert P Mecham; Tracy L Adair-Kirk
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

Review 5.  Oxidative Stress in Chronic Obstructive Pulmonary Disease.

Authors:  Peter J Barnes
Journal:  Antioxidants (Basel)       Date:  2022-05-13

6.  Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.

Authors:  Subramaniam Pennathur; Anuradha Vivekanandan-Giri; Morgan L Locy; Tejaswini Kulkarni; Degui Zhi; Lixia Zeng; Jaeman Byun; Joao A de Andrade; Victor J Thannickal
Journal:  Am J Respir Crit Care Med       Date:  2016-04-15       Impact factor: 21.405

7.  Mouse Models of Oxidative Stress Indicate a Role for Modulating Healthy Aging.

Authors:  Ryan T Hamilton; Michael E Walsh; Holly Van Remmen
Journal:  J Clin Exp Pathol       Date:  2012-06-20

8.  Suppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.

Authors:  George K Acquaah-Mensah; Deepti Malhotra; Madhulika Vulimiri; Jason E McDermott; Shyam Biswal
Journal:  PLoS Comput Biol       Date:  2012-07-19       Impact factor: 4.475

Review 9.  Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer.

Authors:  Mann Ying Lim; Paul S Thomas
Journal:  Int J Chronic Dis       Date:  2013-08-01

Review 10.  Sirtuin 1 and aging theory for chronic obstructive pulmonary disease.

Authors:  V Conti; G Corbi; V Manzo; G Pelaia; A Filippelli; A Vatrella
Journal:  Anal Cell Pathol (Amst)       Date:  2015-07-05       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.